These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16501812)

  • 61. Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic.
    Ghiotto F; Fais F; Tenca C; Tomati V; Morabito F; Casciaro S; Mumot A; Zoppoli G; Ciccone E; Parodi S; Bruno S
    Cancer Biol Ther; 2009 Feb; 8(3):263-71. PubMed ID: 19164937
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
    Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
    Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine.
    Crassini K; Stevenson WS; Mulligan SP; Best OG
    Leuk Lymphoma; 2015; 56(12):3407-17. PubMed ID: 25804768
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Apoptotic effect of fludarabine is independent of expression of IAPs in B-cell chronic lymphocytic leukemia.
    Silva KL; Vasconcellos DV; Castro ED; Coelho AM; Linden R; Maia RC
    Apoptosis; 2006 Feb; 11(2):277-85. PubMed ID: 16502265
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Significance of phosphotyrosine proteins, Bcl-2 and p53 for apoptosis in resting B-chronic lymphocytic leukemia (CLL) cells.
    Laytragoon-Lewin N; Rossmann ED; Castro J; Mellstedt H
    Int J Cancer; 2002 Jan; 97(3):344-8. PubMed ID: 11774286
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
    Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
    Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.
    König A; Menzel T; Lynen S; Wrazel L; Rosén A; Al-Katib A; Raveche E; Gabrilove JL
    Leukemia; 1997 Feb; 11(2):258-65. PubMed ID: 9009090
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model.
    Rebolleda N; Losada-Fernandez I; Perez-Chacon G; Castejon R; Rosado S; Morado M; Vallejo-Cremades MT; Martinez A; Vargas-Nuñez JA; Perez-Aciego P
    PLoS One; 2016; 11(4):e0154159. PubMed ID: 27101369
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax.
    de la Fuente MT; Casanova B; Garcia-Gila M; Silva A; Garcia-Pardo A
    Leukemia; 1999 Feb; 13(2):266-74. PubMed ID: 10025901
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Promising anti-leukemic activity of atorvastatin.
    Żołnierczyk JD; Borowiak A; Hikisz P; Cebula-Obrzut B; Błoński JZ; Smolewski P; Robak T; Kiliańska ZM
    Oncol Rep; 2013 May; 29(5):2065-71. PubMed ID: 23440293
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX.
    McConkey DJ; Chandra J; Wright S; Plunkett W; McDonnell TJ; Reed JC; Keating M
    J Immunol; 1996 Apr; 156(7):2624-30. PubMed ID: 8786328
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
    Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP
    Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism.
    Mengubas K; Riordan FA; Bravery CA; Lewin J; Owens DL; Mehta AB; Hoffbrand AV; Wickremasinghe RG
    Oncogene; 1999 Apr; 18(15):2499-506. PubMed ID: 10229201
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.
    Nückel H; Frey UH; Röth A; Dührsen U; Siffert W
    Eur J Pharmacol; 2005 May; 514(2-3):217-24. PubMed ID: 15910809
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia.
    Consoli U; El-Tounsi I; Sandoval A; Snell V; Kleine HD; Brown W; Robinson JR; DiRaimondo F; Plunkett W; Andreeff M
    Blood; 1998 Mar; 91(5):1742-8. PubMed ID: 9473241
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Bcl-2 and Bax protein interaction in B-lymphocytes of peripheral blood in patients with chronic lymphocytic leukemia].
    Brajusković G; Orolicki SV; Cerović S; Usaj SK; Marjanović S; Romac S
    Vojnosanit Pregl; 2005 May; 62(5):357-63. PubMed ID: 15913039
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro.
    Pepper C; Thomas A; Hoy T; Milligan D; Bentley P; Fegan C
    Blood; 2003 Apr; 101(7):2454-60. PubMed ID: 12446453
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.
    Trachootham D; Zhang H; Zhang W; Feng L; Du M; Zhou Y; Chen Z; Pelicano H; Plunkett W; Wierda WG; Keating MJ; Huang P
    Blood; 2008 Sep; 112(5):1912-22. PubMed ID: 18574029
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Retinoid-induced apoptosis in B-cell chronic lymphocytic leukaemia cells is mediated through caspase-3 activation and is independent of p53, the retinoic acid receptor, and differentiation.
    Pepper C; Ali K; Thomas A; Hoy T; Fegan C; Chowdary P; Kell J; Bentley P
    Eur J Haematol; 2002 Oct; 69(4):227-35. PubMed ID: 12431242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.